Evidence map›Paper›PMID 28288075›Full record

Trial reportMedical care2017

An Electronic Health Record-based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial.

Alex D Federman, Natalie Kil, Joseph Kannry, Evie Andreopolous, Wilma Toribio, Joanne Lyons, Mark Singer, Anthony Yartel, Bryce D Smith, David B Rein and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Alex D Federman*Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai †Mount Sinai Health System, New York, NY ‡Centers for Disease Control and Prevention, Atlanta, GA §NORC at the University of Chicago, Chicago, IL ∥Department of Health Evidence and Policy, Icahn School of Medicine at Mount Sinai, New York, NY ¶Valley Medical Group, Greenfield, MA.
Natalie Kil
Joseph Kannry
Evie Andreopolous
Wilma Toribio
Joanne Lyons
Mark Singer
Anthony Yartel
Bryce D Smith
David B Rein
Katherine Krauskopf
Icahn School of Medicine at Mount Sinai · USMount Sinai Health System · USCenters for Disease Control and Prevention · USUniversity of Chicago · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundThe Centers for Disease Control and Prevention (CDC) recommends one-time hepatitis C virus (HCV) antibody testing for "Birth Cohort" adults born during 1945-1965.

objectiveTo examine the impact of an electronic health record (EHR)-embedded best practice alert (BPA) for HCV testing among Birth Cohort adults.

designCluster-randomized trial was conducted from April 29, 2013 to March 29, 2014. SUBJECTS AND

settingTen community and hospital-based primary care practices. Participants were attending physicians and medical residents during 25,620 study-eligible visits.

interventionPhysicians in all practices received a brief introduction to the CDC testing recommendations. At visits for eligible patients at intervention sites, physicians received a BPA through the EHR to order HCV testing or medical assistants were prompted to post a testing order for the physician. Physicians in control sites did not receive the BPA. MAIN OUTCOMES: HCV testing; the incidence of HCV antibody positive tests was a secondary outcome.

resultsTesting rates were greater among Birth Cohort patients in intervention sites (20.2% vs. 1.8%, P<0.0001) and the odds of testing were greater in intervention sites after controlling for imbalances of patient and visit characteristics between comparison groups [odds ratio (OR), 9.0; 95% confidence interval, 7.6-10.7). The adjusted OR of identifying HCV antibody positive patients was also greater in intervention sites (OR, 2.1; 95% confidence interval, 1.3-11.2).

conclusionsAn EHR-embedded BPA markedly increased HCV testing among Birth Cohort patients, but the majority of eligible patients did not receive testing indicating a need for more effective methods to promote uptake.

Indexed as

Electronic Health RecordsAgedCluster AnalysisDatabases, FactualFemaleHealth PromotionHepacivirusHepatitis C, ChronicHumansMaleMass ScreeningMiddle AgedNew York City

Identifiers

PMID28288075
PMCPMC5759753
OpenAlexW2591942883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.